Biotech ETFs Still in Fragile Spots

MarketsETF Trends

The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotech ETF by assets, is up 7% this month, but some of the post-election ebullience afforded struggling biotechnology stocks and exchange traded funds is waning. However, market observers are growing more bullish on the sector as a Republican-led Congress and administration could enact reforms to free…Click to read more at

Continue Reading Below